SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.
Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.
SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.
Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.
Fetal Magnetic Resonance Imaging (MRI) Requires Prior Authorization
Date: October 11, 2021
Attention: All Providers
Effective Dates: June 1, 2021 for code 74712 and April 1, 2021 for code 74713Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.
Call to action: Network providers submitting a prior authorization for fetal Magnetic Resonance Imaging (MRI) should include a current clinic note dated within 30 days of the authorization request stating the need for the fetal MRI. Fetal MRI (codes 74712 and 74713) is a benefit for pregnant TCHP members.
How this impacts providers: Indications for Fetal MRI include:
An abnormality on ultrasound is not clearly defined and more information is sought in order to make a decision about therapy, delivery, or to advise a family about prognosis (ie: potential anomaly in the setting of maternal obesity, oligohydramnios, or advanced gestational age)
An abnormality is identified on ultrasonography and the treating physician desires MRI-specific information in order to make decisions about care.
A fetus is significantly at risk for abnormality that will affect prognosis even if no finding is discovered with ultrasound (i.e.: neurologic ischemia after laser ablation of placental anastomoses in Twin-Twin Transfusion Syndrome).
